Developing a Preliminary Definition and Domains of Flare in Knee and Hip Osteoarthritis (OA): Consensus Building of the Flare-in-OA OMERACT Group.

Consensus Hip Joint / physiopathology Humans Knee Joint / physiopathology Osteoarthritis, Hip / diagnosis Osteoarthritis, Knee / diagnosis
DOMAIN FLARE HIP KNEE OMERACT OSTEOARTHRITIS

Journal

The Journal of rheumatology
ISSN: 0315-162X
Titre abrégé: J Rheumatol
Pays: Canada
ID NLM: 7501984

Informations de publication

Date de publication:
09 2019
Historique:
accepted: 07 03 2019
pubmed: 17 5 2019
medline: 21 10 2020
entrez: 17 5 2019
Statut: ppublish

Résumé

Flare in knee and hip osteoarthritis (OA) is more than just an exacerbation of pain. Unstructured, semistructured, and focus group interviews followed by Delphi surveys with patients and health professionals (HP) generated candidate domains of an OA flare. Content analysis of interviews with 29 patients and 16 HP extracted 180 statements, which were grouped into 9 clusters. Delphi consensus with 50 patients (Australia, Canada, and France) and 116 HP (17 countries on 4 continents) identified 5 flare domains: pain, swelling, stiffness, psychological aspects, and effect of symptoms. Elements for a preliminary definition of an OA flare are proposed. Registered at clinicaltrials.gov NCT02892058.

Identifiants

DOI: 10.3899/jrheum.181085 PMID: 31092709
pubmed: 31092709
pii: jrheum.181085
doi: 10.3899/jrheum.181085
doi:

Banques de données

ClinicalTrials.gov
['NCT02892058']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1188-1191

Auteurs

Francis Guillemin (F)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada. francis.guillemin@univ-lorraine.fr.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital. francis.guillemin@univ-lorraine.fr.
ORCID: 0000-0002-9860-7024

Camille Ricatte (C)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0003-4165-1734

Annica Barcenilla-Wong (A)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0003-2775-9415

Amandine Schoumacker (A)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.

Marita Cross (M)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0003-2717-8960

Camille Alleyrat (C)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.

Thomas Buttel (T)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.

Michel Cembalo (M)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.

Hakima Manseur (H)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.

Hema Urban (H)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0003-1390-8109

Bruno Fautrel (B)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0001-8845-4274

Philip G Conaghan (PG)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0002-3478-5665

Gillian Hawker (G)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0001-6358-1197

Claudia Rutherford (C)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0002-4637-4572

Lyn March (L)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0003-1736-8111

Elisabeth Spitz (E)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0001-7436-1974

David J Hunter (DJ)

From the INSERM, CIC 1433 Clinical Epidemiology; Université de Lorraine, APEMAC unit, MICS team, Nancy; Université de Lorraine, APEMAC unit, EPSAM team, Metz; Sorbonne Université, GRC 08; AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital, Paris, France; University of Sydney, Institute of Bone and Joint Research, Kolling Institute; Rheumatology Department, Royal North Shore Hospital; Inner West Psychology; Faculty of Science, School of Psychology, and Faculty of Medicine and Health & Nursing School, University of Sydney, Sydney, Australia; Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds; UK National Institute for Health Research (NIHR) Leeds Biomedical Research Centre, Leeds, UK; Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
F. Guillemin, MD, PhD, INSERM, CIC 1433 Clinical Epidemiology, and Université de Lorraine, APEMAC - MICS; C. Ricatte, MSc, Université de Lorraine, APEMAC - EPSAM; A. Barcenilla-Wong, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; A. Schoumacker, MSc, Université de Lorraine, APEMAC - EPSAM; M. Cross, PhD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; C. Alleyrat, MSc, Inserm, CIC 1433 Clinical Epidemiology; T. Buttel, MA, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital, and Inner West Psychology; M. Cembalo, PhD, Frouard, France; H. Manseur, MSc, INSERM, CIC 1433 Clinical Epidemiology; H. Urban, MBiomedSc, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; B. Fautrel, MD, PhD, Sorbonne Université, GRC 08, and AP-HP, Rheumatology Department, Pitié-Salpétrière Hospital; P.G. Conaghan, MD, PhD, Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, and NIHR Leeds Biomedical Research Centre; G. Hawker, MD, PhD, Department of Medicine, University of Toronto; C. Rutherford, PhD, Faculty of Science, School of Psychology, University of Sydney, and Faculty of Medicine and Health & Nursing School, University of Sydney; L. March, MD, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital; E. Spitz, PhD, Université de Lorraine, APEMAC - EPSAM; D.J. Hunter, MBBS, PhD, FRACP, University of Sydney, Institute of Bone and Joint Research, Kolling Institute, and Rheumatology Department, Royal North Shore Hospital.
ORCID: 0000-0003-3197-752X

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Pensée (activité mentale) › Prise de décision › Consensus › Developing a Preliminary Definition and...
questionsmedicales.fr › Appareil locomoteur › Squelette › Articulations › Articulation de la hanche › Developing a Preliminary Definition and...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Developing a Preliminary Definition and...
questionsmedicales.fr › Appareil locomoteur › Squelette › Articulations › Articulation du genou › Developing a Preliminary Definition and...
questionsmedicales.fr › Maladies ostéomusculaires › Arthrose › Coxarthrose › Developing a Preliminary Definition and...
questionsmedicales.fr › Maladies ostéomusculaires › Arthrose › Gonarthrose › Developing a Preliminary Definition and...